BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 7727729)

  • 1. Cancer cytogenetics and molecular genetics: detection and therapeutic strategy.
    Sandberg AA; Chen Z
    In Vivo; 1994; 8(5):807-18. PubMed ID: 7727729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
    Chen Z; Sandberg AA
    Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related acute leukemia.
    Karp JE; Sarkodee-Adoo CB
    Clin Lab Med; 2000 Mar; 20(1):71-81, ix. PubMed ID: 10702897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of chromosome number deviations in myelodysplastic syndromes and in acute non-lymphoid leukemia].
    Balogh E; Oláh E; Nagy A; Kovács I; Kiss A
    Orv Hetil; 1989 Mar; 130(13):655-63. PubMed ID: 2657551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of cytogenetics in leukemias.
    VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
    Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
    Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
    Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytogenetics in the diagnosis of hematologic malignancies.
    Clare N; Hansen K
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):785-807. PubMed ID: 7961291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic features of myelodysplastic syndromes (MDS).
    Willman CL
    Leukemia; 1998 Sep; 12 Suppl 1():S2-6. PubMed ID: 9777886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of hematologic malignancies.
    Yunis JJ; Tanzer J
    Crit Rev Oncog; 1993; 4(2):161-90. PubMed ID: 8420572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic and molecular analysis of the deletions of chromosome 5 in myeloid disorders.
    Le Beau MM
    Prog Clin Biol Res; 1990; 352():277-85. PubMed ID: 2205866
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility to therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Sill H
    Clin Adv Hematol Oncol; 2008 Mar; 6(3):164-5. PubMed ID: 18391913
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
    Lichtman MA
    Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cytogenetics and molecular-genetics - clinical implications (review).
    Sandberg A; Chen Z
    Int J Oncol; 1995 Dec; 7(6):1241-51. PubMed ID: 21552956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetics. An evolving role in the diagnosis and treatment of cancer.
    Glassman AB
    Clin Lab Med; 1997 Mar; 17(1):21-37. PubMed ID: 9138897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of human leukemias: new insights into therapy.
    Gilliland DG
    Semin Hematol; 2002 Oct; 39(4 Suppl 3):6-11. PubMed ID: 12447846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.